rs2305635
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_015175.3(NBEAL2):c.4995G>A(p.Val1665=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.389 in 1,550,500 control chromosomes in the GnomAD database, including 119,430 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.35 ( 9563 hom., cov: 34)
Exomes 𝑓: 0.39 ( 109867 hom. )
Consequence
NBEAL2
NM_015175.3 synonymous
NM_015175.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.438
Genes affected
NBEAL2 (HGNC:31928): (neurobeachin like 2) The protein encoded by this gene contains a beige and Chediak-Higashi (BEACH) domain and multiple WD40 domains, and may play a role in megakaryocyte alpha-granule biogenesis. Mutations in this gene are a cause of gray platelet syndrome. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 3-47002132-G-A is Benign according to our data. Variant chr3-47002132-G-A is described in ClinVar as [Benign]. Clinvar id is 260583.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-47002132-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.438 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.397 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NBEAL2 | NM_015175.3 | c.4995G>A | p.Val1665= | synonymous_variant | 31/54 | ENST00000450053.8 | NP_055990.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NBEAL2 | ENST00000450053.8 | c.4995G>A | p.Val1665= | synonymous_variant | 31/54 | 2 | NM_015175.3 | ENSP00000415034 | P2 | |
NBEAL2 | ENST00000416683.5 | c.2859G>A | p.Val953= | synonymous_variant | 17/40 | 1 | ENSP00000410405 | |||
NBEAL2 | ENST00000443829.5 | c.102G>A | p.Val34= | synonymous_variant | 1/23 | 1 | ENSP00000414560 | |||
NBEAL2 | ENST00000651747.1 | c.4893G>A | p.Val1631= | synonymous_variant | 30/53 | ENSP00000499216 | A2 |
Frequencies
GnomAD3 genomes AF: 0.346 AC: 52658AN: 152012Hom.: 9565 Cov.: 34
GnomAD3 genomes
AF:
AC:
52658
AN:
152012
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.364 AC: 55393AN: 152366Hom.: 10592 AF XY: 0.374 AC XY: 30402AN XY: 81324
GnomAD3 exomes
AF:
AC:
55393
AN:
152366
Hom.:
AF XY:
AC XY:
30402
AN XY:
81324
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.393 AC: 549865AN: 1398370Hom.: 109867 Cov.: 71 AF XY: 0.395 AC XY: 272732AN XY: 689836
GnomAD4 exome
AF:
AC:
549865
AN:
1398370
Hom.:
Cov.:
71
AF XY:
AC XY:
272732
AN XY:
689836
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.346 AC: 52654AN: 152130Hom.: 9563 Cov.: 34 AF XY: 0.348 AC XY: 25921AN XY: 74382
GnomAD4 genome
AF:
AC:
52654
AN:
152130
Hom.:
Cov.:
34
AF XY:
AC XY:
25921
AN XY:
74382
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1086
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Gray platelet syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at